Emergency Medicine General
RSSArticles
-
Bleeding concerns with dabigatran
-
Short course treatment for latent TB
-
All antidepressants are created equal
-
Adverse drug events in the elderly
-
Warfarin testing every 12 weeks?
-
Rivaroxaban for atrial fibrillation patients
Rivaroxaban (Xarelto), Janssen Pharmaceutical's once-a-day oral Xa inhibitor, has been approved for reducing the risk of stroke in patients with atrial fibrillation. -
FDA actions
-
Is it time to retire niacin?
-
News Briefs: Survey: Physicians are worried about the impact of health reform on ED volume
-
Clinical pharmacists with EM training slash medication errors, help to optimize therapies in the ED
Despite continuing pressure to streamline operations, a small but growing number of EDs are adding clinical pharmacists with specialized training in emergency medicine to their ranks.